202 related articles for article (PubMed ID: 31564016)
21. IP-10 differentiates between active and latent tuberculosis irrespective of HIV status and declines during therapy.
Wergeland I; Pullar N; Assmus J; Ueland T; Tonby K; Feruglio S; Kvale D; Damås JK; Aukrust P; Mollnes TE; Dyrhol-Riise AM
J Infect; 2015 Apr; 70(4):381-91. PubMed ID: 25597826
[TBL] [Abstract][Full Text] [Related]
22. Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study.
Santin M; Morandeira-Rego F; Alcaide F; Rabuñal R; Anibarro L; Agüero-Balbín R; Casas-Garcia X; Pérez-Escolano E; Navarro MD; Sánchez F; Coira-Nieto A; Trigo-Daporta M; Martinez-Meñaca A; Gonzalez-Cuevas A; López-Prieto MD; Domínguez-Castellano A; Jové N;
Clin Microbiol Infect; 2016 Dec; 22(12):1007.e1-1007.e5. PubMed ID: 27647563
[TBL] [Abstract][Full Text] [Related]
23. QuantiFERON-TB Gold Plus combined with HBHA-Induced IFN-γ release assay improves the accuracy of identifying tuberculosis disease status.
Tang J; Huang Y; Jiang S; Huang F; Ma T; Qi Y; Ma Y
Tuberculosis (Edinb); 2020 Sep; 124():101966. PubMed ID: 32866942
[TBL] [Abstract][Full Text] [Related]
24. Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?
Whittaker E; Gordon A; Kampmann B
PLoS One; 2008; 3(12):e3901. PubMed ID: 19065267
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of interferon-gamma-induced protein 10 for differentiating active tuberculosis from latent tuberculosis: A meta-analysis.
Qiu X; Tang Y; Zou R; Zeng Y; Yue Y; Li W; Qu Y; Mu D
Sci Rep; 2019 Aug; 9(1):11408. PubMed ID: 31388072
[TBL] [Abstract][Full Text] [Related]
26. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
[TBL] [Abstract][Full Text] [Related]
27. Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study.
Blauenfeldt T; Wagner D; Aabye M; Heyckendorf J; Lange B; Lange C; Ernst M; Ravn P; Duarte R; Morais C; Hoffmann M; Schoch OD; Dominguez J; Latorre I; Ruhwald M
Tuberculosis (Edinb); 2016 May; 98():7-12. PubMed ID: 27156612
[TBL] [Abstract][Full Text] [Related]
28. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
[TBL] [Abstract][Full Text] [Related]
29. Interferon gamma inducible protein-10 in the diagnosis of paediatric tuberculosis infection in a low TB incidence country.
Amanatidou V; Critselis E; Trochoutsou A; Soldatou A; Benetatou K; Spyridis N; Papadopoulos NG; Tsolia MN
Int J Tuberc Lung Dis; 2015 Dec; 19(12):1463-9. PubMed ID: 26614187
[TBL] [Abstract][Full Text] [Related]
30. Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 production.
Jeong YH; Hur YG; Lee H; Kim S; Cho JE; Chang J; Shin SJ; Lee H; Kang YA; Cho SN; Ha SJ
J Clin Microbiol; 2015 Feb; 53(2):504-10. PubMed ID: 25428147
[TBL] [Abstract][Full Text] [Related]
31. Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis.
Qiu X; Xiong T; Su X; Qu Y; Ge L; Yue Y; Zeng Y; Li W; Hu P; Mu D
BMC Infect Dis; 2019 Oct; 19(1):924. PubMed ID: 31666025
[TBL] [Abstract][Full Text] [Related]
32. Could inducible protein-10 and heparin-binding hemagglutinin improve the detection of Mycobacterium tuberculosis-infected subjects in a country with low incidence of tuberculosis?
Molicotti P; Bua A; Cubeddu M; Ruggeri M; Mura MS; Pirina P; Zanetti S
Infect Dis (Lond); 2015 Aug; 47(8):563-7. PubMed ID: 25856090
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers for discrimination between latent tuberculosis infection and active tuberculosis disease.
Won EJ; Choi JH; Cho YN; Jin HM; Kee HJ; Park YW; Kwon YS; Kee SJ
J Infect; 2017 Mar; 74(3):281-293. PubMed ID: 27871809
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a whole-blood chemiluminescent immunoassay of IFN-γ, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
Liang Y; Wang Y; Li H; Yang Y; Liu J; Yu T; Wu X
APMIS; 2016 Oct; 124(10):856-64. PubMed ID: 27523388
[TBL] [Abstract][Full Text] [Related]
35. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection.
Xiao JN; Xiong Y; Chen Y; Xiao YJ; Ji P; Li Y; Wang SJ; Zhao GP; Cheng QJ; Lu SH; Wang Y
Front Cell Infect Microbiol; 2017; 7():495. PubMed ID: 29250493
[TBL] [Abstract][Full Text] [Related]
36. Chemokines additional to IFN-γ can be used to differentiate among Mycobacterium tuberculosis infection possibilities and provide evidence of an early clearance phenotype.
Nonghanphithak D; Reechaipichitkul W; Namwat W; Naranbhai V; Faksri K
Tuberculosis (Edinb); 2017 Jul; 105():28-34. PubMed ID: 28610785
[TBL] [Abstract][Full Text] [Related]
37. The effect of HIV coinfection, HAART and TB treatment on cytokine/chemokine responses to Mycobacterium tuberculosis (Mtb) antigens in active TB patients and latently Mtb infected individuals.
Kassa D; de Jager W; Gebremichael G; Alemayehu Y; Ran L; Fransen J; Wolday D; Messele T; Tegbaru B; Ottenhoff TH; van Baarle D
Tuberculosis (Edinb); 2016 Jan; 96():131-40. PubMed ID: 26631832
[TBL] [Abstract][Full Text] [Related]
38. Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets.
Baumann R; Kaempfer S; Chegou NN; Oehlmann W; Loxton AG; Kaufmann SH; van Helden PD; Black GF; Singh M; Walzl G
J Infect; 2014 Dec; 69(6):581-9. PubMed ID: 24968240
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis of active tuberculosis and latent tuberculosis infection based on Raman spectroscopy and surface-enhanced Raman spectroscopy.
Kaewseekhao B; Nuntawong N; Eiamchai P; Roytrakul S; Reechaipichitkul W; Faksri K
Tuberculosis (Edinb); 2020 Mar; 121():101916. PubMed ID: 32279876
[TBL] [Abstract][Full Text] [Related]
40. Combination of HLA-DR on
Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
Front Immunol; 2021; 12():761209. PubMed ID: 34858413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
